This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Coronavirus Test Kit Demand to Drive These 3 Stocks
by Zacks Equity Research
Point-of-care testing enables better patient triage, bed management, and patient care decisions. Here are three stocks to benefit as demand rises.
Has Co-Diagnostics (CODX) Outpaced Other Medical Stocks This Year?
by Zacks Equity Research
Is (CODX) Outperforming Other Medical Stocks This Year?
The Zacks Analyst Blog Highlights: Regeneron Pharmaceuticals, Co-Diagnostics, Moderna and Vertex Pharmaceuticals
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Regeneron Pharmaceuticals, Co-Diagnostics, Moderna and Vertex Pharmaceuticals
4 Top Biotech Stocks to Buy in the Time of Coronavirus
by Tirthankar Chakraborty
We have picked biotech companies that are widely expected to develop a vaccine for the coronavirus and fight off the worst stock market carnage since the 2008 financial crisis.
The Zacks Analyst Blog Highlights: Netflix, Microsoft, Sempra Energy, Co-Diagnostics and Moderna
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Netflix, Microsoft, Sempra Energy, Co-Diagnostics and Moderna
Top Ranked Momentum Stocks to Buy for March 16th
by Zacks Equity Research
Here are three stocks with buy rank and strong momentum characteristics for investors to consider today, March 16th.
5 Smart Ways to Profit From the Coronavirus Crisis
by Tirthankar Chakraborty
Even though majority of investors are in a state of shock, many know how to profit during uncertain times like these. Here're five ways you can put your money to work amid the coronavirus outbreak.
Beat Virus With 2 Sector ETFs & Stocks That Survived 2008 Crisis
by Sanghamitra Saha
These two sectors lost lesser than the broader market during the 2008 financial crisis and may help you to tide over the latest virus crisis.
The Zacks Analyst Blog Highlights: Co-Diagnostics, GenMark Diagnostics, OPKO Health and Inovio Pharmaceuticals
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Co-Diagnostics, GenMark Diagnostics, OPKO Health and Inovio Pharmaceuticals
The Zacks Analyst Blog Highlights: Buckle, Chipotle Mexican Grill, Co-Diagnostics, Moderna and Regeneron Pharmaceuticals
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Buckle, Chipotle Mexican Grill, Co-Diagnostics, Moderna and Regeneron Pharmaceuticals
4 Stocks to Gain the Most From the Coronavirus Outbreak
by Nilanjan Banerjee
It is worthwhile to keep an eye on stocks of companies that are engaged in the prevention, diagnosis and treatment of the disease.
5 Stocks to Win Big From Trump's Economic Stimulus
by Tirthankar Chakraborty
Trump floats financial aids to counter the impact of the coronavirus outbreak. Notable stimulus measures include payroll tax cut, aid for wage earners and an emergency funding worth $8.3 billion
Co-Diagnostics, Inc. (CODX) Shares March Higher, Can It Continue?
by Zacks Equity Research
As of late, it has definitely been a great time to be an investor in Co-Diagnostics, Inc. (CODX).
Top Ranked Momentum Stocks to Buy for March 10th
by Zacks Equity Research
Here are four stocks with buy rank and strong momentum characteristics for investors to consider today, March 10th
3 Correction-Defying Bets to Buy as Markets Brave Coronavirus
by Manaswita Ghosh Dutta
Global markets lost $6 trillion in the week ended Feb 29 as coronavirus triggered sharp selloff. Here's how to play the dip.
The Zacks Analyst Blog Highlights: Co-Diagnostics, Regeneron Pharmaceuticals, Netflix, Norwegian Cruise Line and American Airlines
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Co-Diagnostics, Regeneron Pharmaceuticals, Netflix, Norwegian Cruise Line and American Airlines
4 Top Stocks to Win Big From the Coronavirus Pandemic (Revised)
by Tirthankar Chakraborty
Professional money managers are looking to buy stocks that act as a hedge against coronavirus threat, or those that simply benefits from the particular event.
Is Co-Diagnostics (CODX) Stock Outpacing Its Medical Peers This Year?
by Zacks Equity Research
Is (CODX) Outperforming Other Medical Stocks This Year?
Best & Worst Performing Stocks in Coronavirus Outbreak
by Tirthankar Chakraborty
Here're the big winners and losers since the coronavirus outbreak brought the U.S. bull market to a standstill.
The Zacks Analyst Blog Highlights: Moderna, Inovio Pharmaceuticals, Co-Diagnostics and Apple
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Moderna, Inovio Pharmaceuticals, Co-Diagnostics and Apple
4 Top Stocks to Win Big From the Coronavirus Pandemic
by Tirthankar Chakraborty
Professional money managers are looking to buy stocks that act as a hedge against coronavirus threat, or those that simply benefits from the particular event.
The Zacks Analyst Blog Highlights: Co-Diagnostics, VAXART, Sprint, Stamps.com and Uniti
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Co-Diagnostics, VAXART, Sprint, Stamps.com and Uniti
Top Ranked Momentum Stocks to Buy for March 2nd
by Zacks Equity Research
Here are three stocks with buy rank and strong momentum characteristics for investors to consider today, March 2nd.
Market in Correction: 5 Stocks Resist Virus Attack in February
by Sanghamitra Saha
Wall Street has entered into the correction territory after steep coronavirus-induced selloffs in February. But these stocks have gained massively.
The Wining Sector & Its Top Stocks in Virus-Infected January
by Sanghamitra Saha
January has turned out great for biotech stocks thanks to the coronavirus outbreak as well as a general upbeat trend.